# Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With Nephropathy

> **NCT04549324** · — · COMPLETED · sponsor: **University of Aarhus** · enrollment: 74 (actual)

## Conditions studied

- Sleep Apnea
- Diabetic Nephropathy Type 2
- Coronary Atheroscleroses
- Heart Insufficiency
- Arterial Stiffness
- Kidney Diseases
- Vascular Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04549324
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-01
- **Primary completion:** 2022-01-24
- **Final completion:** 2022-01-24
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2022-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04549324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04549324, "Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With Nephropathy". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04549324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*